Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Paratek Pharmaceuticals Inc (NASDAQ:PRTK)

12.92
Delayed Data
As of Jul 22
 +0.09 / +0.70%
Today’s Change
12.05
Today|||52-Week Range
28.74
-31.89%
Year-to-Date
No recent news for Paratek Pharmaceuticals Inc.

Today’s Trading

Previous close12.83
Today’s open12.87
Day’s range12.69 - 13.02
Volume102,118
Average volume (3 months)217,049
Market cap$283.1M
Dividend yield5.17%
Data as of 3:59pm ET, 07/22/2016

Growth & Valuation

Earnings growth (last year)+45.14%
Earnings growth (this year)-33.18%
Earnings growth (next 5 years)+274.70%
Revenue growth (last year)-100.00%
P/E ratioNM
Price/Sales--
Price/Book2.25

Competitors

 Today’s
change
Today’s
% change
HSKAHeska Corp-0.97-2.24%
AGTCApplied Genetic Tech...+0.05+0.32%
COLLCollegium Pharmaceut...+0.03+0.25%
CRVSCorvus Pharmaceutica...+0.07+0.50%
Data as of 3:59pm ET, 07/22/2016

Financials

Next reporting dateAugust 3, 2016
EPS forecast (this quarter)-$1.62
Annual revenue (last year)$0.00
Annual profit (last year)-$70.9M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Chief Executive Officer
Michael F. Bigham
President, Director &
Chief Medical Officer
Evan Loh
Corporate headquarters
Boston, Massachusetts

Forecasts

Partner Offers

Search for Jobs